Health care stakeholders struggling to comply with the HIPAA 5010 transaction sets need not worry about one thing-- the next-generation 6020 transactions are not coming to a theater near you any time soon.
The 6020 transactions are being developed and are undergoing a public comment period that closes on March 7, 2012. But Accredited Standards Committee X12, developer of the HIPAA transactions, will not soon recommend adoption of technical reports, called TR3s, which would be a major step toward adoption of 6020.
The committee recognizes that the industry is not ready to begin another implementation cycle at this time, says ASC X12 chair Cathy Sheppard. However, public comments on the 6020 technical reports still are important in shaping the next version of HIPAA transactions to meet business needs.
More information is available athttp://forums.x12.org.
Source: Health Data Management
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More